Fungal Infection Testing + Diagnostics for Human Health

Since 2002, MiraVista Diagnostics has been developing and evolving our menu of diagnostic tests for fungal infections. We work with hospital labs, research university labs, government and municipal labs, physician practices, large reference labs and CROs across the country to detect, analyze and monitor a wide range of serious mycology infections that afflict their patients. This includes antigen and antibody detection tests for aspergillus, blastomyces dermatitidis, histoplasma capsulatum, coccidioides, cryptococcus and beta-D-glucan.

Accurate Test Results Lead to Better Patient Outcomes

MiraVista Diagnostics understands the critical role we play in the health care and health science continuum. Because we take that responsibility seriously, we are committed to partnering with clinicians to consistently deliver:

Superior clinical standards in testing accuracy and sensitivity
Rapid response and test results
Dedication to excellent client service and customer satisfaction
Direct access to our infectious disease experts
Quality assurance across our organization
Compliance with regulatory mandates and industry best practices
Continuous product and service improvement

Company News

Fungal Infection Testing + Diagnostics for Human Health

Accurate Test Results Lead to Better Patient Outcomes

Now Available: MVista® Pulmonary Fungal Pathogen PCR Panel

American College of Chest Physicians (CHEST)

Infectious Disease Society of America (IDWeek)

MiraVista Institutional Biosafety Committee (IBC) Announcement

American College of Chest Physicians Boston, MA October 6-9, 2024

ID WEEK Los Angeles, CA October 16-20, 2024